Approximately 80% of the cases related to familial breast cancer are associated with one gene of hereditary susceptibility for breast and ovarian cancer, BRCA1 and BRCA2. The BRCA genes have been classified as tumour-suppressor genes, because the loss of wild-type allele has been observed in tumors of heterozygous carriers. The gene discussed is BRCA2; the disease is ovarian carcinoma.